ArticleFrontiers in endocrinology2026
Sodium-glucose cotransporter-2 inhibitors in cancer patients with type 2 diabetes and established immune checkpoint inhibitor-related cardiotoxicity: a retrospective analysis.
Ling Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.